Results 161 to 170 of about 708,008 (375)

OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.

open access: yesOsteoarthritis and Cartilage, 2019
Raveendhara R. Bannuru   +22 more
semanticscholar   +1 more source

Pharmaceutical Treatment of Osteoarthritis.

open access: yesOsteoarthritis and Cartilage, 2022
M. J. Richard, J. Driban, T. McAlindon
semanticscholar   +1 more source

Single‐Cell Dissection of the Biological Function and Molecular Features Underlying the Micropeptide LSMEM1 in Kidney

open access: yesAdvanced Science, EarlyView.
LSMEM1, an evolutionarily conserved micropeptide with extreme hydrophobicity (aliphatic index═113) and dynamic amphiphilicity (GRAVY═0.017), features a strong α‐helical transmembrane anchor (residues 64‐86). Single‐cell analysis reveals its critical role in renal lipid homeostasis.
Peimin Liu   +11 more
wiley   +1 more source

Constructing Dual‐Atomic Fe─Fe Sites Nanozyme for Targeted Osteoarthritis Therapy through Mitigating Oxidative Stress and Cartilage Degeneration

open access: yesAdvanced Science, EarlyView.
A novel bimetallic nanozyme (Fe2–NCs) with well‐defined Fe–Fe active sites is synthesized through a host–guest coordination strategy, which exhibits an exceptional therapeutic efficacy in osteoarthritis therapy. Experimental and theoretical analyses uncover the intrinsic catalytic mechanism at the atomic level, offering fundamental insights and design ...
Ting Ying   +6 more
wiley   +1 more source

Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health [PDF]

open access: gold, 2015
Usman Ahmed   +12 more
openalex   +1 more source

Clustering of comorbidities and associated outcomes in people with osteoarthritis - A UK Clinical Practice Research Datalink study

open access: green, 2022
Subhashisa Swain   +10 more
openalex   +2 more sources

Epidemiology of Osteoarthritis.

open access: yesOsteoarthritis and Cartilage, 2021
Kelli D. Allen, L. Thoma, Y. Golightly
semanticscholar   +1 more source

Osteoarthritis [PDF]

open access: yesActa Orthopaedica Scandinavica, 1998
openaire   +2 more sources

Targeted Inhibition of CD74+ Macrophages by Luteolin via CEBPB/P65 Signaling Ameliorates Osteoarthritis Progression

open access: yesAdvanced Science, EarlyView.
This study identifies CD74⁺ macrophages as key drivers of synovial inflammation in osteoarthritis (OA). The flavonoid luteolin is predicted to inhibit this pathway by blocking Nuclear Factor Kappa‐light‐chain‐enhancer of Activated B cells (NF‐κB) signaling. To enhance delivery, a targeted nanoplatform (MDSPL) is developed.
Rui Peng   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy